Evidence map›Paper›PMID 33788172›Full record

ArticleAging clinical and experimental research2021

Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country.

Abdullah M Alguwaihes, Shaun Sabico, Rana Hasanato, Mohammed E Al-Sofiani, Maram Megdad, Sakhar S Albader, Mohammad H Alsari, Ali Alelayan, Ebtihal Y Alyusuf, Saad H Alzahrani and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Aging clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Vitamin D Status and Its Association with Multiple Intelligence among Arab Adolescents.International journal of environmental research and public health · 2021
    Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Vitamin D and COVID-19: where are we now?Postgraduate medicine · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Association of Vitamin D Knowledge, Behavior and Attitude with BMI Status among Arab Adults.International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Abdullah M Alguwaihes *Division of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. aalguwaihes@ksu.edu.sa.
Shaun Sabico *Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
Rana HasanatoPathology Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mohammed E Al-SofianiDivision of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Maram MegdadGeneral Directorate of Health Affairs in Eastern Province, Dammam, Saudi Arabia.
Sakhar S AlbaderKing Saud University Medical City, Riyadh, Saudi Arabia.
Mohammad H AlsariKing Saud University Medical City, Riyadh, Saudi Arabia.
Ali AlelayanKing Saud University Medical City, Riyadh, Saudi Arabia.
Ebtihal Y AlyusufDivision of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Saad H AlzahraniObesity, Endocrine and Metabolism Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Nasser M Al-DaghriBiochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
Anwar A JammahDivision of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SADammam Central Hospital · SAJohns Hopkins Medicine · USKing Fahd Medical City · SAKing Saud Medical City · SA

Funding

King Saud University RSP 2020/21
6 · The paper itself

Abstract

purposeAs the world continues to cautiously navigate its way through the coronavirus disease 2019 (COVID-19) pandemic, several breakthroughs in therapies and vaccines are currently being developed and scrutinized. Consequently, alternative therapies for severe acute respiratory coronavirus 2 (SARS-CoV-2) prevention, such as vitamin D supplementation, while hypothetically promising, require substantial evidence from countries affected by COVID-19. The present retrospective case-control study aims to identify differences in vitamin D status and clinical characteristics of hospitalized patients screened for SARS-CoV-2, and determine associations of vitamin D levels with increased COVID-19 risk and mortality.

methodsA total of 222 [SARS-CoV-2 (+) N = 150 (97 males; 53 females); SARS-CoV-2 (-) N = 72 (38 males, 34 females)] out of 550 hospitalized adult patients screened for SARS-CoV-2 and admitted at King Saud University Medical City-King Khalid University Hospital (KSUMC-KKUH) in Riyadh, Saudi Arabia from May-July 2020 were included. Clinical, radiologic and serologic data, including 25(OH)D levels were analyzed.

resultsVitamin D deficiency (25(OH)D < 50 nmol/l) was present in 75% of all patients. Serum 25(OH)D levels were significantly lower among SARS-CoV-2 (+) than SARS-CoV-2 (-) patients after adjusting for age, sex and body mass index (BMI) (35.8 ± 1.5 nmol/l vs. 42.5 ± 3.0 nmol/l; p = 0.037). Multivariate regression analysis revealed that significant predictors for SARS-CoV-2 include age > 60 years and pre-existing conditions (p < 0.05). Statistically significant predictors for mortality adjusted for covariates include male sex [Odds ratio, OR 3.3 (95% confidence interval, CI 1.2-9.2); p = 0.02], chronic kidney disease [OR 3.5 (95% CI 1.4-8.7); p = 0.008] and severe 25(OH)D deficiency (< 12.5 nmol/l), but at borderline significance [OR 4.9 (95% CI (0.9-25.8); p = 0.06].

conclusionIn hospital settings, 25(OH)D deficiency is not associated with SARS-CoV-2 infection, but may increase risk for mortality in severely deficient cases. Clinical trials are warranted to determine whether vitamin D status correction provides protective effects against worse COVID-19 outcomes.

Indexed as

COVID-19Vitamin D DeficiencyArabsCase-Control StudiesFemaleHumansMaleRetrospective StudiesSARS-CoV-2Saudi ArabiaVitamin DVitamin DCase–controlCOVID-19Saudi ArabiaSevere vitamin D deficiencyVitamin D

Identifiers

PMID33788172
PMCPMC8009930
OpenAlexW3144190294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.